China Isotope forms RMB 50 million joint venture with CNNC Zhejiang Science and Technology Innovation

• China Isotope & Radiation Corporation signed a shareholders’ agreement on July 28, 2026 to form joint venture CNNC Fuzhi with CNNC Zhejiang Science and Technology Innovation.
• Registered capital set at RMB 50 million; China Isotope will contribute RMB 45 million for a 90% stake.
• Contribution includes RMB 26.6 million cash by Dec. 31, 2026, plus RMB 18.4 million of Nuclear Medicine Development Center net assets by Dec. 31, 2027.
• Partner will invest RMB 5 million cash for 10%, split between Dec. 31, 2026 and Dec. 31, 2027; venture becomes a non-wholly-owned subsidiary.
• JV will take over the Nuclear Medicine Development Center business, targeting “intelligent nuclear medicine” integration across software, pharmaceuticals, and equipment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Isotope & Radiation Corporation published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260728-12259570), on July 28, 2026, and is solely responsible for the information contained therein.